Search Results - Y.-Z. Wang
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
-
5
PB1821: COMBINATION OF BCL-2 INHIBITOR, HYPOMETHYLATION AGENTS AND LOW-DOSE CYTARABINE AS A SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES by X.-N. Gao, X. Lou, J. Lin, Y.-F. Su, J. Wang, L. Xu, H. Yu, A. Wang, Y.-Z. Wang, D.-H. Liu
Published in HemaSphere (2022-06-01)Get full text
Article -
6
P1417: PROPHYLACTIC NAC PROMOTED HEMATOPOIETIC RECONSTITUTION BY IMPROVING ENDOTHELIAL CELLS AFTER HSCT: A PHASE 3, OPEN-LABEL RANDOMIZED TRIAL by Y. Wang, Y. Kong, H.-Y. Zhao, Y.-Y. Zhang, Y.-Z. Wang, L.-P. Xu, X.-H. Zhang, K.-Y. Liu, X.-J. Huang
Published in HemaSphere (2022-06-01)Get full text
Article -
7
P533: SINGLE-CENTER PHASE 2 STUDY OF PD-1 INHIBITOR COMBINED WITH DNA DEMETHYLATION AGENT + CAG REGIMEN IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA: INTERIM ANALYSIS by X.-N. Gao, Y.-F. Su, Y. Jing, J. Wang, L. Xu, L.-L. Zhang, A. Wang, Y.-Z. Wang, Y.-F. Li, D.-H. Liu
Published in HemaSphere (2022-06-01)Get full text
Article
